News

Filter

Current filters:

None

28 to 37 of 96906 results

Clovis Oncology's rucaparib achieves positive Phase II results

Clovis Oncology's rucaparib achieves positive Phase II results

20-11-2014

Personalized cancer therapy specialist Clovis Oncology has achieved positive results in a Phase II trial…

BiotechnologyClovis OncologyOncologyResearchrucaparibUSA

UK's Cell Therapy Catapult launches searchable funding database for cell research

UK's Cell Therapy Catapult launches searchable funding database for cell research

20-11-2014

The Cell Therapy Catapult, focused on developing the UK cell industry, has teamed up with the UK Regenerative…

Cell Therapy CatapultResearchStem cellsUKUnited Kingdom

HHS and NIH take steps to enhance clinical trial results transparency

20-11-2014

The US Department of Health and Human Services today issued a Notice of Proposed Rulemaking (NPRM), which…

PharmaceuticalRegulationResearchUSA

Global medicines spending to rise 30% by 2018 to $1.3 trillion, says IMS

20-11-2014

More specialty drug innovation, greater patient access to medicines and reduced impact from patent expiries…

Sanofi and Regeneron’s dupilumab gets Breakthrough designation from FDA

20-11-2014

The US Food and Drug Administration has granted Breakthrough Therapy designation to French pharma major…

BiotechnologyDermatologicalsdupilumabRegeneronRegulationSanofiUSA

Shire to relocate 500 employees in formation of new hub in Lexington, Massachusetts

Shire to relocate 500 employees in formation of new hub in Lexington, Massachusetts

19-11-2014

Following AbbVie’s recent abandonment of a $53 billion takeover offer, Ireland-headquartered drugmaker…

Business FinancePharmaceuticalPunctuationShireUSA

Royalty Pharma pays $3.3 billion for CFF royalty rights to Kalydeco

19-11-2014

Royalty Pharma says it has acquired royalties on Vertex Pharmaceuticals' cystic fibrosis treatments,…

BiotechnologyFinancialKalydecoRare diseasesRoyalty PharmaVertex Pharmaceuticals

Valeant admits disappointment at loss of takeover target Allergan to Actavis

Valeant admits disappointment at loss of takeover target Allergan to Actavis

19-11-2014

Canadian drugmaker Valeant International has admitted that the loss of hostile takeover target Allergan…

ActavisAllerganCanadaMergers & AcquisitionsPharmaceuticalValeant

28 to 37 of 96906 results

Back to top